ACADIA Pharmaceuticals Inc. news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

ACAD 35.57 -0.98 (-2.68%)
price chart
Needham Weighs In on ACADIA Pharmaceuticals Inc. (ACAD) Following Meeting With ...
Needham analyst Alan Carr was out today with a favorable report on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), after meeting with management for a corporate update and hosting a series of meetings with investors.
Significant Movements: Endo International plc (NASDAQ:ENDP) , ACADIA ...
Endo International plc (NASDAQ:ENDP) diminished -2.78%, closing at $17.50 after floating between $17.30 and $18.18. The company has market capitalization of $3.90B.
ACADIA Pharmaceuticals (ACAD) Shares are Up 10.76%  TheFounders Daily
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Updated Price Targets  FTSE News
How Analysts Rated ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Last Week?
Out of 4 analysts covering ACADIA Pharmaceuticals (NASDAQ:ACAD), 3 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 75% are positive.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Analyst Rating in Focus  Investor Newswire
Biotech Stocks Worth Chasing: ACADIA Pharmaceuticals Inc. (ACAD), Merrimack ...
ACADIA Pharmaceuticals Inc. (ACAD) ended last trading session with a change of 4.07 percent. It trades at an average volume of 2.61M shares versus 3.16M shares recorded at the end of last trading session.
Time To Put On The Watch List? - ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD ...  The Voice Registrar
ACADIA Pharmaceuticals Inc.'s Shareholders Are Having a Crazy Year. Here's Why
What: It's been a wild year for shareholders of Acadia Pharmaceuticals (NASDAQ:ACAD), a commercial-stage biopharma focused on diseases of the central nervous system.
Biotech Companies To Look Out For: Ariad Pharmaceuticals Inc. (ARIA), ACADIA ...  Zergwatch
Is $60 Price Target Attainable For ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)?
Zacks uses a rating methodology that is presented in a simple sliding scale of 1 to 5. In that scale, 3 represents HOLD rating while the numbers that fall on the left hand-side of 3 (1 and 2) indicate a BUY recommendation.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Is In The Spotlight  Markets Daily
Acadia Pharmaceuticals Inc.: Why ACAD Stock Will Be Volatile Over the Next Year
Acadia Pharmaceuticals Inc. (ACAD) has been the model of inconsistency and unpredictability over the last year. Acadia Pharmaceuticals Inc.: Why ACAD Stock Will Be Volatile Over The Next Year ACAD is currently trading right in the middle of its 52-week ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Analyst Research Summary:  Zergwatch
Sizzling Stocks to Track: Sunrun Inc (NASDAQ:RUN), Red Hat Inc (NYSE:RHT ...  iStreetWire
Active Biotech Stock News: Novavax, Inc. (NVAX), ACADIA Pharmaceuticals Inc ...
ACADIA Pharmaceuticals Inc. (ACAD) recently recorded 0.76 percent change and currently at $33.25 is 99.82 percent away from its 52-week low and down -35.11 percent versus its peak.
State Street Corp Has $94072000 Stake in Acadia Pharmaceuticals Inc. (ACAD)  The Cerbat Gem
Recommendation Trends Analysis: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)  News Oracle
HC Stocks Vigilant: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Agilent ...
Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) ended Friday session in green amid volatile trading. The shares closed up +0.49 points or 1.36% at $36.55 with 1,522,494 shares getting traded.
Acadia Pharmaceuticals: What Is Next For Nuplazid?
Since writing my first article on Acadia Pharmaceuticals back at the beginning of June, shares have fallen from $41.50 to $34.50, a decline of about 16.8%.
HC Stocks Judgment: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Athersys, Inc ...  share market updates (press release)
Short Term Rating on ACADIA Pharmaceuticals (ACAD)  TheFounders Daily